Home LiteratureArticle Details
PMID: 2444713 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.

Journal of virology ·Vol. 61 ·No. 11 ·1987-11-00 ·Pages 3356-64

Highlander SL, Sutherland SL, Gage PJ, Johnson DC, Levine M, Glorioso JC

Abstract

Nine monoclonal antibodies specific for glycoprotein D (gD) of herpes simplex virus type 1 were selected for their ability to neutralize virus in the presence of complement. Four of these antibodies exhibited significant neutralization titers in the absence of complement, suggesting that their epitope specificities are localized to site(s) which contribute to the role of gD in virus infectivity. Each of these antibodies was shown to effectively neutralize virus after virion adsorption to cell surfaces, indicating that neutralization did not involve inhibition of virus attachment. Although some of the monoclonal antibodies partially inhibited adsorption of radiolabeled virions, this effect was only observed at concentrations much higher than that required to neutralize virus and did not correlate with complement-independent virus-neutralizing activity. All of the monoclonal antibodies slowed the rate at which virus entered cells, further suggesting that antibody binding of gD inhibits virus penetration. Experiments were carried out to determine the number of different epitopes recognized by the panel of monoclonal antibodies and to identify epitopes involved in complement-independent virus neutralization. Monoclonal antibody-resistant (mar) mutants were selected by escape from neutralization with individual gD-specific monoclonal antibodies. The reactivity patterns of the mutants and antibodies were then used to construct an operational antigenic map for gD. This analysis identified a minimum of six epitopes on gD that could be grouped into four antigenic sites. Antibodies recognizing four distinct epitopes contained in three antigenic sites were found to neutralize virus in a complement-independent fashion. Moreover, mar mutations in these sites did not affect the processing of gD, rate of virus penetration, or the ability of the virus to replicate at high temperature (39 degrees C). Taken together, these results (i) confirm that gD is a major target antigen for neutralizing antibody, (ii) indicate that the mechanism of neutralization can involve inhibition of virus penetration of the cell surface membrane, and (iii) strongly suggest that gD plays a direct role in the virus entry process.

MeSH Terms
Animals Antibodies, Monoclonal Cell Line Epitopes/analysis Genetic Variation Humans Hybridomas/immunology Kinetics Mice Mice, Inbred BALB C Neutralization Tests Simplexvirus/immunology,physiology Vero Cells Viral Envelope Proteins/immunology,physiology Viral Plaque Assay
Chemicals
Antibodies, Monoclonal Epitopes Viral Envelope Proteins glycoprotein D, Human herpesvirus 1
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Highlander S L
Department of Microbiology, University of Michigan Medical School, Ann Arbor 48109.
Sutherland S L
Gage P J
Johnson D C
Levine M
Glorioso J C
References (47)
47 references, click to expand
  1. Specificity of human natural killer cells in limiting dilution culture for determinants of herpes simplex virus type 1 glycoproteins.
    J Virol. 1986 Jan;57(1):294-300 PMID: 2416952
  2. Glycopeptides of the type-common glycoprotein gD of herpes simplex virus types 1 and 2.
    J Virol. 1983 Jun;46(3):679-89 PMID: 6304338
  3. Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production.
    J Virol. 1986 Jul;59(1):142-53 PMID: 2423702
  4. Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("native" gel) system of polyacrylamide gel electrophoresis coupled with Western blotting.
    J Virol. 1986 Oct;60(1):157-66 PMID: 2427745
  5. Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates.
    J Virol. 1986 Nov;60(2):470-5 PMID: 3021981
  6. Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis.
    Science. 1987 May 1;236(4801):576-9 PMID: 3033824
  7. Electron microscopy of herpes simplex virus. I. Entry.
    J Virol. 1968 May;2(5):507-16 PMID: 4301316
  8. Viropexis of herpes simplex virus by HeLa cells.
    Virology. 1969 Mar;37(3):475-80 PMID: 4305028
  9. Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion.
    J Virol. 1972 Jan;9(1):143-59 PMID: 4110104
  10. The role of type specific and cross reacting structural antigens in the neutralization of herpes simplex virus types 1 and 2.
    J Gen Virol. 1973 May;19(2):217-33 PMID: 4351780
  11. Herpes simplex virus-specific polypeptides studied by polyacrylamide gel electrophoresis of immune precipitates.
    J Gen Virol. 1974 Feb;22(2):171-85 PMID: 4362401
  12. Comparison of the virion proteins specified by herpes simplex virus types 1 and 2.
    J Virol. 1975 Nov;16(5):1327-31 PMID: 171455
  13. Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells.
    J Virol. 1976 Mar;17(3):991-1008 PMID: 176453
  14. Ammonium chloride inhibits cell fusion induced by syn mutants of herpes simplex virus type 1.
    J Virol. 1977 Jul;23(1):213-5 PMID: 196105
  15. Type-common CP-1 antigen of herpes simplex virus is associated with a 59,000-molecular-weight envelope glycoprotein.
    J Virol. 1978 Jul;27(1):172-81 PMID: 80458
  16. Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity.
    J Virol. 1979 Mar;29(3):1149-58 PMID: 221669
  17. Evidence for herpes simplex virus type-selective receptors on cellular plasma membranes.
    J Gen Virol. 1979 Jul;44(1):217-25 PMID: 227992
  18. Immunoglobulin G(Fc)-binding receptors on virions of herpes simplex virus type 1 and transfer of these receptors to the cell surface by infection.
    J Virol. 1980 May;34(2):512-20 PMID: 6246278
  19. Differences in attachment between herpes simplex type 1 and type 2 viruses to neurons and glial cells.
    Infect Immun. 1980 Jun;28(3):675-80 PMID: 6249749
  20. Early events in herpes simplex virus type 1 infection: photosensitivity of fluorescein isothiocyanate-treated virions.
    Proc Natl Acad Sci U S A. 1981 Feb;78(2):912-6 PMID: 6262783
  21. Method for induction of mutations in physically defined regions of the herpes simplex virus genome.
    J Virol. 1981 Apr;38(1):41-9 PMID: 6264113
  22. A virion-associated glycoprotein essential for infectivity of herpes simplex virus type 1.
    Virology. 1981 Nov;115(1):149-60 PMID: 6270896
  23. Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4.
    Infect Immun. 1981 Dec;34(3):684-92 PMID: 6277788
  24. Effect of monoclonal antibodies on limited proteolysis of native glycoprotein gD of herpes simplex virus type 1.
    J Virol. 1982 Feb;41(2):478-88 PMID: 6176725
  25. Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody.
    J Virol. 1982 Mar;41(3):1099-1104 PMID: 6284965
  26. Herpes simplex virus type-1 glycoprotein D gene: nucleotide sequence and expression in Escherichia coli.
    Science. 1982 Oct 22;218(4570):381-4 PMID: 6289440
  27. Nucleotide sequences of herpes simplex virus type 1 (HSV-1) affecting virus entry, cell fusion, and production of glycoprotein gb (VP7).
    Virology. 1982 Oct 30;122(2):411-23 PMID: 6293179
  28. Anti-gD monoclonal antibodies inhibit cell fusion induced by herpes simplex virus type 1.
    Virology. 1983 Aug;129(1):218-24 PMID: 6310880
  29. Synthesis and processing of glycoprotein D of herpes simplex virus types 1 and 2 in an in vitro system.
    J Virol. 1983 Nov;48(2):521-33 PMID: 6312106
  30. Cell receptors for the mammalian reovirus. I. Syngeneic monoclonal anti-idiotypic antibody identifies a cell surface receptor for reovirus.
    J Immunol. 1983 Nov;131(5):2533-8 PMID: 6313805
  31. DNA sequence of the Herpes simplex virus type 2 glycoprotein D gene.
    Gene. 1983 Dec;26(2-3):307-12 PMID: 6323270
  32. Nucleotide sequence specifying the glycoprotein gene, gB, of herpes simplex virus type 1.
    Virology. 1984 Mar;133(2):301-14 PMID: 6324454
  33. Mouse Ia antigens are receptors for lactate dehydrogenase virus.
    Nature. 1984 May 3-9;309(5963):59-61 PMID: 6585645
  34. Localization of a type-specific antigenic site on herpes simplex virus type 2 glycoprotein D.
    J Virol. 1984 Jul;51(1):263-5 PMID: 6202883
  35. Nucleotide sequence of a region of the herpes simplex virus type 1 gB glycoprotein gene: mutations affecting rate of virus entry and cell fusion.
    Virology. 1984 Aug;137(1):185-90 PMID: 6089415
  36. Binding to cells of virosomes containing herpes simplex virus type 1 glycoproteins and evidence for fusion.
    J Virol. 1984 Oct;52(1):238-47 PMID: 6090699
  37. Fine structure analysis of type-specific and type-common antigenic sites of herpes simplex virus glycoprotein D.
    J Virol. 1984 Nov;52(2):431-5 PMID: 6208376
  38. Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites.
    J Virol. 1985 Jan;53(1):128-36 PMID: 2578193
  39. Characterisation and physical mapping of an HSV-1 glycoprotein of approximately 115 X 10(3) molecular weight.
    Virology. 1984 Dec;139(2):408-13 PMID: 6097034
  40. Localization of epitopes of herpes simplex virus type 1 glycoprotein D.
    J Virol. 1985 Feb;53(2):634-44 PMID: 2578577
  41. Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1.
    J Mol Biol. 1985 Jan 5;181(1):1-13 PMID: 2984429
  42. Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies.
    J Virol. 1985 Aug;55(2):475-82 PMID: 2991570
  43. Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions.
    J Virol. 1985 Aug;55(2):483-8 PMID: 2991571
  44. Purification of a HeLa cell receptor protein for group B coxsackieviruses.
    J Virol. 1985 Sep;55(3):560-6 PMID: 2991580
  45. AN ELECTRON MICROSCOPE STUDY OF THE ATTACHMENT AND PENETRATION OF HERPES VIRUS IN BHK21 CELLS.
    Virology. 1963 Sep;21:112-23 PMID: 14062901
  46. PENETRATION OF HERPES SIMPLEX VIRUS INTO HUMAN EPIDERMOID CELLS.
    Proc Soc Exp Biol Med. 1964 Aug-Sep;116:863-9 PMID: 14230373
  47. An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralization.
    J Gen Virol. 1986 Jun;67 ( Pt 6):1001-13 PMID: 2423636
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1987-11-00
Pages
3356-64
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC255929
Subset
IM
Grants
NIAID NIH HHS · AI18228 · United States
NIGMS NIH HHS · GM34534 · United States
NCRR NIH HHS · RR00200 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]